游客发表

【dodge challenger hellcat 1/4 mile time】Recap: Mallinckrodt Q1 Earnings

发帖时间:2024-10-04 05:08:08

Shares of Mallinckrodt (NYSE:

MNK

【dodge challenger hellcat 1/4 mile time】Recap: Mallinckrodt Q1 Earnings


) were unchanged in pre-market trading after the company reported Q1 results.

【dodge challenger hellcat 1/4 mile time】Recap: Mallinckrodt Q1 Earnings


Quarterly Results

【dodge challenger hellcat 1/4 mile time】Recap: Mallinckrodt Q1 Earnings


Earnings per share decreased 15.46% over the past year to $1.64,dodge challenger hellcat 1/4 mile time which beat the estimate of $1.48.


Revenue of $665,800,000 less by 15.79% year over year, which missed the estimate of $693,310,000.


Looking Ahead


Earnings guidance hasn't been issued by the company for now.


Revenue guidance hasn't been issued by the company for now.


Details Of The Call


Date: May 05, 2020


View more earnings on MNK


Webcast URL:


https://edge.media-server.com/mmc/p/u396hdtk


Price Action


52-week high: $17.40


52-week low: $1.00


Price action over last quarter: down 16.03%


Company Description


Mallinckrodt PLC develops, manufactures, markets and distributes specialty pharmaceutical products and therapies. Its areas of focus include autoimmune and rare diseases in specialty areas like neurology, rheumatology, nephrology, pulmonology and ophthalmology; immunotherapy and neonatal respiratory critical care therapies; analgesics and gastrointestinal products. The company operates its business in two reportable segments namely Specialty Brands that includes innovative specialty pharmaceutical brands; and Specialty Generics that includes niche specialty generic drugs and active pharmaceutical ingredients.


See more from Benzinga


16 Healthcare Stocks Moving In Monday's Pre-Market Session


20 Healthcare Stocks Moving In Wednesday's Pre-Market Session


© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.


View comments


    热门排行

    友情链接